コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rs (pro-Crps) by matrix metalloproteinase-7 (MMP-7).
2 ro-HNP-1 and beta-defensins, are targets for MMP-7.
3 l extension, and pro-HBD-3 were resistant to MMP-7.
4 nditions associated with increased levels of MMP-7.
5 tivities consistent with MMP-12 and possibly MMP-7.
6 rp4 and pro-Crp4 molecules to degradation by MMP-7.
7 ulfide variants were degraded extensively by MMP-7.
8 on of substrate with the catalytic pocket of MMP-7.
9 ound in the cell wall of fungi, both induced MMP-7.
10 and two of those sites were also cleaved by MMP-7.
11 ad of casein as a substrate for assaying rat MMP-7.
12 of the net charge of JR2EC upon digestion by MMP-7.
13 f matrix metalloproteinases (MMPs) MMP-3 and MMP-7.
14 ed enzymatic activities of MMP-2, MMP-3, and MMP-7.
15 e-regulate a target promoter such as that of MMP-7.
16 e peptides against proteolytic processing by MMP-7.
17 ture 36-residue form of HBD-1 was cleaved by MMP-7.
20 ading MMP, such as MMP-2 (67%), MMP-3 (63%), MMP-7 (62%), and MMP-9 (60%) in hairless mouse skin.
22 ation depends on matrix metalloproteinase 7 (MMP-7), a proteinase expressed in most metaplastic epith
23 rapid and sensitive detection of matrilysin (MMP-7, a biomarker involved in the degradation of variou
30 inar transdifferentiation, it was found that MMP-7 activity was sufficient to induce the process, ind
35 s) are tightly bound to tissues; matrilysin (MMP-7), although the smallest of the MMPs, is one of the
36 de substrate for matrix metalloproteinase-7 (MMP-7), an enzyme that is upregulated in many cancers, t
40 more than 90% recovery was accomplished for MMP-7 and C3a, showing promise for isothermal vitrificat
44 at several invasion-related genes, including MMP-7 and MMP-15, are upregulated in cadherin-11-express
45 The 58-kDa bands derived from plasminogen by MMP-7 and MMP-9 both have the N-terminal sequence KVYLSE
47 In a bid to define the roles of host-derived MMP-7 and MMP-9 in the tumor-bone microenvironment, the
49 e tumor-bone microenvironment, the tibias of MMP-7 and MMP-9 null mice were injected with osteolytic
50 tumor-bone microenvironment, and, of these, MMP-7 and MMP-9 were found to be localized to bone-resor
53 lar mass of fragment D-dimer, obtained after MMP-7 and MT1-MMP degradation of XL-Fb, is similar to th
56 tion induced the expression and secretion of MMP-7 and promoted the binding of T cell factor to the M
57 inase-7 (MMP-7), but the association between MMP-7 and Wnt/beta-catenin signaling in chronic kidney d
59 the gelatinases (MMP-2 and -9), matrilysin (MMP-7) and collagenases (MMP-1 and -13) are difficult to
60 metalloproteinase (MMP) family, matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9), hyd
61 tive matrix metalloproteinase 7 (matrilysin, MMP-7) and heparin-binding epidermal growth factor precu
62 rocessing enzyme matrix metalloproteinase 7 (MMP-7) and its inhibitor TIMP-1 (tissue inhibitor of mat
63 5 on human gelatinase B (MMP-9), matrilysin (MMP-7), and membrane-type 1 MMP (MT1-MMP) was further ex
66 or vacA, completely attenuated induction of MMP-7, and inhibition of ERK 1/2 decreased MMP-7 product
69 he matrix metalloproteinases (MMP)-2, MMP-3, MMP-7, and MMP-9, and basic fibroblast growth factor, wh
72 ge sites obtained by proteolysis with MMP-3, MMP-7, and MT1-MMP were found to be in very close proxim
75 mutant precursors of each were digested with MMP-7, and the cleavage products were analyzed by NH(2)-
76 recursor within this complex is processed by MMP-7, and the resulting mature HB-EGF engages and activ
77 In vitro, cag(+) isolates selectively induce MMP-7, and this is dependent on activation of ERK 1/2 by
79 t on matrilysin (matrix metalloproteinase 7 [MMP-7]) and stromelysin-2 (MMP-10), two MMPs induced by
80 compared apolipoprotein E (apoE)/MMP-3, apoE/MMP-7, apoE/MMP-9, and apoE/MMP-12 double knockouts with
85 ver a novel role of the tubular beta-catenin/MMP-7 axis in controlling the fate of interstitial fibro
86 he mTOR pathway via TLR9 receptor to induced MMP-7, beta-glucan-stimulated cells were mTOR-independen
87 or the effect of matrix metalloproteinase 7 (MMP-7) blood concentration and other demographic and cli
89 deficient mice showed that MMP-9, MMP-3, and MMP-7 but not MMP-2 or MMP-12 are needed for resistance.
93 onally regulates matrix metalloproteinase-7 (MMP-7), but the association between MMP-7 and Wnt/beta-c
98 he addition of heparin to the enzyme sample, MMP-7 can be detected at a level of 30 pg in transferrin
100 und significantly elevated expression of the MMP-7, CCND1 (Cyclin D1), CX43 (Connexin 43), PPAR-delta
101 expression in tumor cells by transfection of MMP-7 cDNA in antisense orientation resulted in sensitiz
108 ne cortical slice preparations, we show that MMP-7 cleaves the NR1 subunit of the N-methyl-d-aspartat
111 rast, enhanced FasL shedding, by recombinant MMP-7, completely protected neurons from Abeta neurotoxi
113 ire direct bacterial exposure, and the basal MMP-7 content of germ-free Paneth cells is sufficient to
115 lammation is increased within the context of MMP-7 deficiency, which involves both Th1- and Th17-medi
117 formation, we showed that the combination of Mmp-7 deletion and EC4-Fc overexpression significantly i
122 f ONO-4817 and galardin for MMP-1, MMP-2 and MMP-7 determined by the proposed colorimetric method was
124 the initiation of procryptdin processing by MMP-7 does not require direct bacterial exposure, and th
127 ate both in vitro and in vivo that exogenous MMP-7 enhances proNGF cleavage and provides neuroprotect
128 following seizures are stabilized by altered MMP-7 enzymatic activity, leading to increased neuronal
130 that molecular signals capable of initiating MMP-7 expression also have the potential to induce forma
134 that selective and coordinated induction of mmp-7 expression by H. pylori cag(+) isolates may explai
136 -catenin signaling by paricalcitol inhibited MMP-7 expression in diseased kidneys and reduced the lev
138 through ectopic expression of Wnt1 promoted MMP-7 expression in vivo, whereas delivery of the gene e
139 taset revealed patterns of Kaiso, MTG16, and MMP-7 expression supporting the hypothesis that loss of
150 Results from our study suggest that common MMP-7 genetic polymorphisms may contribute to breast can
151 ollagen-specific region of the N-propeptide; MMP-7 had another cleavage site close to the COOH termin
156 a cell surface complex composed of CD44HSPG, MMP 7, HB-EGF, and ErbB4 that may play an important role
157 predictive of poor transplant-free survival; MMP-7, ICAM-1, and IL-8 of overall survival; and ICAM-1
165 es indicate that the selective inhibition of MMP-7 in the tumor-bone microenvironment may be of benef
166 l inhibits the activity of human matrilysin (MMP-7) in vitro, suggesting that it might limit proteoly
173 propose that the solubilization of RANKL by MMP-7 is a potential mechanism through which MMP-7 media
177 (2) terminus occurs at Gly(61), not Leu(59), MMP-7 is necessary but insufficient to complete the proc
180 The matrix metalloproteinase matrilysin (MMP-7) is expressed in the tumor cells of a majority of
181 ere we show that matrix metalloproteinase-7 (MMP-7) is expressed not only in the majority of human pa
182 determined to be an excellent substrate for MMP-7 (K(M) = 43 microM, V(max) = 1.3 x 10(-)(8) M s(-1)
185 uterine and mammary epithelia of these mice, MMP-7 localization is altered and pro-HB-EGF processing
190 the activity of matrix metalloproteinase-7 (MMP-7, matrilysin) in vitro, suggesting that this oxidan
193 with Wnt/beta-catenin activity, and urinary MMP-7 may be a noninvasive biomarker of this profibrotic
194 provide evidence that one mechanism whereby MMP-7 may promote tumor survival and resistance to doxor
195 ndicate that H. pylori-mediated induction of MMP-7 may serve to protect the gastric mucosa from patho
197 , studies with recombinant protein show that MMP-7-mediated cleavage of NR1 occurs at amino acid 517,
198 h membrane bilayers and to determine whether MMP-7-mediated proteolysis activates the membrane disrup
200 intestine were significantly up-regulated in MMP-7(-/-) mice compared with that in control C57BL/6 mi
201 d that matrix metalloproteinase-7-deficient (MMP-7(-/-)) mice, which produce procryptdins but not mat
202 Enhanced gastritis in H. pylori-infected mmp-7-/- mice is strongly linked to accelerated epitheli
205 ed expression of MMP-14, while MMP-2, MMP-3, MMP-7, MMP-12, and MMP-13 were not induced by this pepti
207 nd were analyzed for levels of MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-12, MPO, and TIMP-1 using multi
209 The matrix metalloproteinases MMP-2, MMP-3, MMP-7, MMP-9, and MMP-13 are highly expressed in the tum
210 the in vitro IC(50) values for MMP-1, MMP-2, MMP-7, MMP-9, and MMP-14 for at least 4 h after the admi
218 As demonstrators of the assay's utility, MMP-7 mRNA was expression profiled from several colorect
220 oluble RANKL were significantly lower in the MMP-7 null mice compared with wild-type (WT) controls.
222 n Lewis lung carcinoma tumor number, whereas MMP-7 null mice showed a 42% increase in tumor number, a
224 ce of processed CRS4C in protein extracts of MMP-7-null mouse ileum demonstrates the in vivo requirem
226 entical conditions, mice either deficient in MMP-7 or carrying an inactive FasL gene are severely inh
228 lood vessel density, whereas deficiencies in MMP-7 or MMP-9 did not influence tumor growth or surviva
232 In contrast, fragments generated by MMP-2, MMP-7, or plasmin had no effect on macrophage proteinase
236 Furthermore, cleavage of OPN by MMP-3 or MMP-7 potentiated the function of OPN as an adhesive and
240 l of pancreatic acinar-to-ductal metaplasia, MMP-7 progressively accumulates during the metaplastic t
244 of precursors by matrix metalloproteinase-7 (MMP-7), prompting an analysis of the relative sensitivit
246 . pylori cag(+) strains selectively increase MMP-7 protein levels in gastric epithelial cells in vitr
248 S4C-1 peptide by matrix metalloproteinase-7 (MMP-7) proteolysis of the precursor proregion at the sam
249 proteolytic cleavage of the stalk region by MMP-7 reduced the bioactivity of sFasL in human cells in
250 , or deletion of matrix-metalloproteinase-7 (Mmp-7) reduced VSMC apoptosis in mouse atherosclerotic p
251 IA procollagen in situ, we demonstrated that MMP-7 removes the NH(2)-propeptide from collagen fibrils
253 hat lack disulfide bonding contain a cryptic MMP-7-sensitive site within the mature peptide moiety.
255 -gene biomarker panel (COL1A2, COL3A1, UMOD, MMP-7, SERPING1, TIMP1) classified AR with high specific
257 o-stage study to evaluate the association of MMP-7 single nucleotide polymorphisms (SNPs) with breast
258 This study examined the effects of MMP-1 and MMP-7-sparing inhibition (sMMPi) on regional and global
260 as associated with autolytic cleavage of pro-MMP-7, strongly suggesting that oxygenation activates th
263 Therefore, the ability of osteoclast-derived MMP-7 to promote RANKL solubilization in the tumor-bone
265 Mature HNP-1 was resistant to processing by MMP-7 unless the peptide was reduced and alkylated, demo
268 ls, each natural log unit increment in serum MMP-7 was associated with a 3.7% absolute decrement in F
274 nfirmed that overexpression of cyclin D1 and MMP-7 was highly associated with nuclear accumulation of
277 ull mice, we report that macrophage-produced MMP-7 was required for proteoglycan degradation, loss of
280 and activated by matrix metalloproteinase-7 (MMP-7), we determined if additional defensin molecules,
283 system by participating in the secretion of MMP-7 which in turn is important for the shedding of Syn
284 renal induction of matrix metalloproteinase (MMP-7), which induced FasL expression in interstitial fi
287 , we show that one member of the MMP family, MMP-7, which may be released from cells, including micro
288 transcription of its target genes MMP-1 and MMP-7, which regulate extracellular matrix in the prosta
289 o cleaved following treatment of slices with MMP-7, while select AMPA receptor subunits are not.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。